A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Actym Therapeutics, Inc.
Incyte Corporation
Checkpoint Therapeutics, Inc.
Mabpro, a.s.
Quadriga Biosciences, Inc.
Xencor, Inc.
AbbVie
Shionogi Inc.
Masonic Cancer Center, University of Minnesota
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Chicago